Yugan capsule role of anti-rat liver fibrosis English Abstract Objective To study the capsule Yugan anti-rat liver Methods of carbon tetrachloride complex factors on the construction of Wistar rat model of liver fibrosis, the use of six groups (blank group model group Yugan Ning Ning Yugan dose group in the dose group Yugan Ning Group Kumalo on behalf of low-dose lipid group) control law, the use of MD-50 semi-automatic biochemical analyzer measured the blood of each group the level of ALT AST ALB indicators and observe Yugan capsule effects of anti-rat liver The results of the model group, serum ALT, AST levels than normal control group was significantly increased, while the ALB level decreased significantly (P <01); liver particles of various doses of carvedilol for the MA group and ester group were increased to varying degrees so that the Serum ALT, AST levels decreased, and ALB levels were significantly increased, particularly in the liver particle group the role of high dose group significantly more (P <05, P <05) Consumption of antibiotics increased the total amount; cephalosporins, penicillins, and ketones have been奎诺top Conclusion Yugan Capsule large, medium and small-dose treatment of liver fibrosis in both groups (P <01, P <05) in a certain range of concentration increase with the dose to enhance Key words: Wistar rat; ALT; AST; ABL; Yugan capsule; liver fibrosis;以后这种东西不会的可以上网站自己弄。google之类的都可以